| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/31/2008 | EP1429600B1 An invertebrate animal model with alzheimer-like pathology for screening and testing molecules |
| 12/31/2008 | EP1423151B1 Light-stabilized in vivo stain composition and method of manufacture |
| 12/31/2008 | EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 12/31/2008 | EP0743860B2 Preparation of hollow microcapsules |
| 12/31/2008 | CN201171714Y Self-inhalation type nano-granule contaminated box |
| 12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
| 12/31/2008 | CN101332125A Preparation method of acetic acid inducted rat individual same-size gastric ulcer model |
| 12/31/2008 | CN101332122A Construction method of body surface fistula rat animal model |
| 12/31/2008 | CN100447145C 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 12/30/2008 | US7470763 Free radical addition polymerization; for medical diagnosis |
| 12/30/2008 | US7470698 Adenosine A3 receptor modulators |
| 12/30/2008 | US7470431 Administering a therapeutic amount of a botulinum toxin into the prostate gland of a patient with prostate cancer, thereby alleviating a symptom of prostate cancer or its treatment |
| 12/30/2008 | CA2355269C Materials and methods for making improved micelle compositions |
| 12/30/2008 | CA2250295C Water soluble paclitaxel prodrugs |
| 12/30/2008 | CA2197683C Method for preparing an influenza virus, antigens obtained and applications thereof |
| 12/25/2008 | US20080320609 Diabetes Model Animal |
| 12/25/2008 | US20080319320 Method of imaging lymphatic system using nanocapsule compositions |
| 12/25/2008 | US20080319315 Method of reducing interferences in positron emission tomography |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/25/2008 | US20080317676 Biocompatible Fluorescent Imaging Agents |
| 12/25/2008 | US20080317675 Low Osmolar X-Ray Contrast Media Formulations |
| 12/25/2008 | US20080317674 Method and Reagent for Measuring Nitroreductase Enzyme Activity |
| 12/25/2008 | US20080317673 Method for diagnosing and treating bronchial asthma |
| 12/25/2008 | US20080317671 Non-imidazole heterocyclic compounds |
| 12/25/2008 | US20080317670 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 12/25/2008 | US20080317669 Cloning of honey bee allergen C |
| 12/25/2008 | US20080317668 Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications |
| 12/25/2008 | US20080317666 Colonic Delivery of Active Agents |
| 12/24/2008 | WO2008156460A1 Bioconjugated nanoparticles |
| 12/24/2008 | WO2008155330A1 Diagnostic substance and method for the diagnosis of prostate diseases |
| 12/24/2008 | WO2008155093A1 Hyperpolarization of compounds for nmr, in particular by means of phip |
| 12/24/2008 | WO2008134618A3 Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
| 12/24/2008 | WO2008023064A3 Use of a composition for skin treatment during x-ray irradiation |
| 12/24/2008 | WO2006088508A3 Cupredoxin derived transport agents and methods of use thereof |
| 12/24/2008 | EP2005972A1 Contrast agents for medical devices |
| 12/24/2008 | EP2005971A1 Contrast agents for medical devices |
| 12/24/2008 | EP2005970A1 Imaging diagnosis by combining contrast agents |
| 12/24/2008 | EP2005160A2 Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system |
| 12/24/2008 | EP2004242A2 Systems and methods for cell measurement utilizing ultrashort t2* relaxometry |
| 12/24/2008 | EP2004241A2 Implantable sensor |
| 12/24/2008 | EP2004155A1 Inhibitors of protein aggregation |
| 12/24/2008 | EP1545502A4 Keto cannabinoids with therapeutic indications |
| 12/24/2008 | EP1521741B1 Imaging compounds |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | DE102007028777A1 Transportvorrichtung Transport device |
| 12/24/2008 | DE102007028659A1 Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen Diagnostic substance and method for the diagnosis of prostate disease |
| 12/24/2008 | CN101327226A Light-emitting microorganisms and cells for tumour diagnosis/therapy |
| 12/24/2008 | CA2691243A1 Thrombin inhibitor |
| 12/24/2008 | CA2687716A1 Hyperpolarization of compounds for nmr, in particular by means of phip |
| 12/23/2008 | US7468418 Compositions for enhancing transport of molecules into cells |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468190 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages |
| 12/23/2008 | US7468178 drug screening; inducing sleep; side effect reduction |
| 12/23/2008 | US7468177 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 12/23/2008 | CA2371321C Novel high viscosity embolizing compositions |
| 12/23/2008 | CA2371176C Assays for nucleoside diphosphates and triphosphates |
| 12/23/2008 | CA2332039C The use of a vital dye for facilitating surgical procedures for vitreo-retinal surgery |
| 12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
| 12/23/2008 | CA2219641C Diagnostic composition |
| 12/23/2008 | CA2212750C Humanized antibodies against cd3 |
| 12/18/2008 | WO2008154641A1 Methods of screening an agent in an isolated eye of a teleost |
| 12/18/2008 | WO2008154332A1 Near-infrared dyes as surface enhanced raman scattering reporters |
| 12/18/2008 | WO2008154043A2 Near-infrared responsive carbon nanostructures |
| 12/18/2008 | WO2008153928A2 Method of reducing interferences in positron emission tomography |
| 12/18/2008 | WO2008153744A2 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 12/18/2008 | WO2008152490A2 Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging |
| 12/18/2008 | WO2008152109A1 Measurement of neural activity |
| 12/18/2008 | WO2008151749A2 Activatable diagnostic and therapeutic compound |
| 12/18/2008 | WO2008118691A3 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/18/2008 | WO2008080112A3 New fusion molecule based on novel taa variant |
| 12/18/2008 | WO2007142667A3 Treatment of patients with autoantibody positive disease |
| 12/18/2008 | US20080312325 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 12/18/2008 | US20080312219 Biologically active methylene blue derivatives |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311048 Imaging Agent |
| 12/18/2008 | US20080311047 Multimetric Biosensors and Methods of Using Same |
| 12/18/2008 | US20080311046 Ultrasound Contrast Agent |
| 12/18/2008 | US20080311045 Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| 12/18/2008 | US20080311044 Methods of determining hair follicle inductive properties |
| 12/18/2008 | US20080311043 Uses and compositions for treatment of psoriatic arthritis |
| 12/18/2008 | US20080311042 Loop-Variant Pdz Domains as Biotherapeutics, Diagnostics and Research Reagents |
| 12/18/2008 | US20080311041 Water-Soluble, Fluorescent Compounds for Detection of Potassium Ions |
| 12/18/2008 | US20080311040 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| 12/18/2008 | US20080311039 Therapeutic and Prognostic Factor Yy1 in Human Cancer |
| 12/18/2008 | US20080311037 Compounds which bind PSMA and uses thereof |
| 12/18/2008 | US20080308744 Serum Albumin Conjugated to Fluorescent Substances for Imaging |
| 12/18/2008 | DE102007028090A1 Aktivierbare diagnostische und therapeutische Verbindung Activatable diagnostic and therapeutic compound |
| 12/18/2008 | DE102007027285A1 Vorrichtung, geeignet um in den menschlichen und/oder tierischen Körper eingebracht zu werden An apparatus adapted to be introduced into the human and / or animal body |
| 12/18/2008 | CA2687178A1 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 12/17/2008 | EP2002714A1 Novel gene disruptions, compositions and methods relating thereto |
| 12/17/2008 | EP2002258A2 Use of gelsolin to treat multiple sclerosis and to diagnose neurologic diseases |
| 12/17/2008 | EP2001534A2 Drug adherence monitoring system |
| 12/17/2008 | EP2001520A2 Diagnostic systems and methods utilizing probe-ions exhibiting photon avalanche effect |
| 12/17/2008 | EP1572695B1 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy |
| 12/17/2008 | EP1306380B1 Novel expanded porphyrins and process for the synthesis thereof |
| 12/17/2008 | EP1206287B1 High viscosity embolizing compositions |
| 12/17/2008 | EP1181571B1 Method of magnetic resonance imaging |
| 12/17/2008 | CN101325978A Novel imaging agents for fibrosis |
| 12/17/2008 | CN101325977A System and method for monitoring in vivo drug release using overhauser-enhanced NMR |
| 12/17/2008 | CN101323022A Method for preparing gold magnetic core-shell nano-particle |